We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Prescription medicine

16 December 2019 By Robyn Mak

Soaring medical costs in the People’s Republic have prompted Jack Ma’s $150 bln Ant Financial and others to offer insurance-like solutions. A scandal involving a Tencent-backed upstart, though, is a reminder the sector is largely unregulated. That’s unlikely to remain the case.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)